Literature DB >> 2890425

Anatomy and pathology of the basal ganglia.

P L McGeer1, E G McGeer, S Itagaki, K Mizukawa.   

Abstract

Neurotransmitters of the basal ganglia are of three types: I, amino acids; II, amines; and III, peptides. The amino acids generally act ionotropically while the amines and peptides generally act metabotropically. There are many examples of neurotransmitter coexistence in basal ganglia neurons. Diseases of the basal ganglia are characterized by selective neuronal degeneration. Lesions of the caudate, putamen, subthalamus and substantia nigra pars compacta occur, respectively, in chorea, dystonia, hemiballismus and parkinsonism. The differing signs and symptoms of these diseases constitute strong evidence of the functions of these various nuclei. Basal ganglia diseases can be of genetic origin, as in Huntington's chorea and Wilson's disease, of infectious origin as in Sydenham's chorea and postencephalitic parkinsonism, or of toxic origin as in MPTP poisoning. Regardless of the etiology, the pathogenesis is often regionally concentrated for reasons that are poorly understood. From studies on Parkinson and Huntington disease brains, evidence is presented that a common feature may be the expression of HLA-DR antigen on reactive microglia in the region where pathological neuronal dropout is occurring.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2890425     DOI: 10.1017/s0317167100037756

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  6 in total

1.  Dystonia-parkinsonism syndrome (XDP) locus: flanking markers in Xq12-q21.1.

Authors:  K G Kupke; M B Graeber; U Müller
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

Review 2.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

3.  Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease.

Authors:  R Thangavel; D Stolmeier; X Yang; P Anantharam; A Zaheer
Journal:  Neuropathol Appl Neurobiol       Date:  2012-10       Impact factor: 8.090

4.  Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.

Authors:  L A Mattiace; P Davies; D W Dickson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

5.  Delineation of the dystonia-parkinsonism syndrome locus in Xq13.

Authors:  M B Graeber; K G Kupke; U Müller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.